Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC)
Source Title
A Phase1 Results of a Non-Stabilized Spike-Encoding mRNA Vaccine in Adults
Year
2022
Volume
N/A
Page
N/A
Format
PDF
Abstract
Effective COVID-19 mRNA vaccines are mainly available in high-income countries. ChulaCov19, a prefusion non-stabilized Spike protein-encoding, nucleoside-modified mRNA, lipid nanoparticle encapsulated vaccine development, aims to enhance accessibility of mRNA vaccine and future pandemic preparedness for low- to middle-income countries.
